Tactiva Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 03, 2018
- Vertical
- Immuno-oncology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founders
- Matthew Colpoys
- Company Description
- Tactiva Therapeutics is a development stage immuno-oncology company
- Market
- Cancer treatment
- Location
- Buffalo, NY, USA
- Coinvestors
- Efung Capital, Panacea Ventures, Vi-Ventures